Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Nov;5(6):605-7.
doi: 10.1586/ecp.12.54.

Emerging pharmacotherapy for treatment of Graves' disease

Rebecca S Bahn
Editorial

Emerging pharmacotherapy for treatment of Graves' disease

Rebecca S Bahn. Expert Rev Clin Pharmacol. 2012 Nov.
No abstract available

PubMed Disclaimer

References

    1. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–738. - PMC - PubMed
    1. Bahn Chair RS, Burch HB, Cooper DS, et al. American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646. - PubMed
    1. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905–917. - PubMed
    1. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med. 1998;338(2):73–78. - PubMed
    1. Träisk F, Tallstedt L, Abraham-Nordling M, et al. Thyroid Study Group of TT 96. Thyroid-associated ophthalmopathy after treatment for Graves’ hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab. 2009;94(10):3700–3707. - PubMed

Publication types

MeSH terms